Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Cardinal Health Inc. (CAH - Analyst Report) revealed that it has renewed its three-year supplier agreement with St. Paul, Minn.-based medical supplies provider Prime Therapeutics. CAH supplies pharmaceuticals for Prime's pharmacy home delivery service, PrimeMail, and Prime Therapeutics Specialty Pharmacy.

Prime manages more than $15 billion in prescription drugs per year and serves about 23 million members. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

Prime’s specialty pharmacy helps boost the health of people having rheumatoid arthritis, hepatitis C and multiple sclerosis, through personalized care management programs. As part of the agreement, CAH will continue to supply additional supply chain optimization services to boost operational efficiency of Prime.

Cardinal Health posted solid fiscal 2014 first-quarter adjusted earnings of $1.10 per share, which were up 36% from 81 cents earned in the year-ago quarter. Earnings per share comfortably surpassed the Zacks Consensus Estimate of 85 cents by an impressive margin of 29.4%.

Revenues in the first quarter went down 5% to $24,523 million, due to lower revenues from the Pharmaceutical segment. Nonetheless, the top line beat the Zacks Consensus Estimate of $22,680 million.

For fiscal 2014, CAH raised its forecast for adjusted earnings per share to the band of $3.62 to $3.72 from the earlier guidance of $3.45 to $3.60. Management cited the company’s outstanding fiscal first-quarter results along with efficient operating performance as the reason behind the upgraded guidance. The current Zacks Consensus Estimate of $3.69 for the year lies within the outlook band.

Cardinal Health currently has a Zacks Rank #2 (Buy). Other stocks in the medical/dental supplies industry that are currently worth a look include Align Technology Inc. (ALGN - Analyst Report), McKesson Corporation (MCK - Analyst Report), and Merit Medical Systems, Inc. (MMSI - Snapshot Report).  All of them carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%